We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PNR:NYSEPentair plc. Analysis

Data as of 2026-09-08 - not real-time

$58.62

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Pentair plc trades at $58.62, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 7.2% over the past 30 days. Momentum indicators put RSI at 30.1 (approaching oversold) with MACD reading bearish. Recent trading has carved out support near $58.61 and resistance around $68.23.
On valuation the read is undervalued — earnings multiple of 15.1 versus a 28.3 sector average, below the peer group. Sell-side targets cluster 30.2% above the current quote. Revenue is contracting at 17.0% on a 16.2% profit margin. The 1.76% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 31.3%, a beta of 0.98 and a maximum drawdown of 47.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.

Top Market Events

NEW YORK, Sept. 02, 2026 GLOBE NEWSWIRE -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been...Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public...Kaplan Fox Alerts Pentair Plc NYSE: PNR Investors Who Suffered Losses To A Securities Class Action Deadline Is October...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 85.50
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 15.1 versus sector average of 28.3
  • Trading below the 200-day average of 85.50

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 15.1 versus sector average of 28.3
  • Analyst targets imply +30.2% versus the current price
  • Profit margin of 16.2% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth-17.00%
Profit Margin16.24%
P/E Ratio15.1
ROE17.13%
ROA8.66%
Debt/Equity47.07
P/B Ratio2.5
Op. Cash Flow$751.5M
Free Cash Flow$558.3M
Industry P/E28.3

Technical Analysis

TrendBearish
RSI30.1
Support$58.61
Resistance$68.23
MA 20$62.97
MA 50$66.69
MA 200$85.50
MACDBearish
VolumeIncreasing
Fear & Greed Index93.36

Valuation

Fair Value$33.74
Target Price$76.31
Upside/Downside30.17%
GradeUndervalued
TypeBlend
Dividend Yield1.76%

Risk Assessment

Beta0.98
Volatility31.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.